Efficacy of 5-azacytidine in a TET2 mutated angioimmunoblastic T cell lymphoma

Br J Haematol. 2015 Mar;168(6):913-6. doi: 10.1111/bjh.13170. Epub 2014 Oct 14.
No abstract available

Keywords: 5-azacytidine; TET2 mutation; angioimmunoblastic T cell lymphoma; epigenetic.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antineoplastic Agents / therapeutic use*
  • Azacitidine / therapeutic use*
  • DNA Mutational Analysis / methods
  • DNA, Neoplasm / genetics
  • DNA-Binding Proteins / genetics*
  • Dioxygenases
  • Female
  • Humans
  • Immunoblastic Lymphadenopathy / drug therapy*
  • Leukemia, Myelomonocytic, Chronic / complications
  • Lymphoma, T-Cell, Peripheral / drug therapy*
  • Mutation
  • Proto-Oncogene Proteins / genetics*

Substances

  • Antineoplastic Agents
  • DNA, Neoplasm
  • DNA-Binding Proteins
  • Proto-Oncogene Proteins
  • Dioxygenases
  • TET2 protein, human
  • Azacitidine